Business Insider

Global Bispecific Antibodies Therapy Blincyto Hemlibra Antibody Therapeutics Market Size To Witness 118% Growth To Reach US$ 10 Billion By 2026

DELHI, India, Oct. 07, 2020 (GLOBE NEWSWIRE) -- "Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 2026" Report Highlights: Download ...
Business Insider

Global $10+ Billion Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight, 2026

Dublin, Feb. 04, 2020 (GLOBE NEWSWIRE) -- The "Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering.
Business Wire

ImmunoPrecise Presents Novel T-Cell Engaging Bispecific Antibodies Addressing a Unique Oncological Target, Tropomyosin Receptor Kinase B, Associated with Poor Prognosis and ...

ImmunoPrecise’s Unique Proprietary Bispecific Antibodies Link Cells Expressing Tumor-Associated Antigen Tropomyosin Receptor Kinase B (TrkB) with CD3-Positive T Cells, Immune System Cells that Respond ...
Business Wire

Thomas Manley, M.D. Joins Rondo Therapeutics as Chief Medical Officer to Lead Clinical Development of Rondo Therapeutics’ Bispecific Antibody Programs

HAYWARD, Calif.--(BUSINESS WIRE)--Rondo Therapeutics, a private biopharmaceutical company pioneering next-generation bispecific antibody platforms, has named Thomas Manley, M.D., as Chief Medical ...